0001209191-21-018051.txt : 20210305 0001209191-21-018051.hdr.sgml : 20210305 20210305060848 ACCESSION NUMBER: 0001209191-21-018051 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210301 FILED AS OF DATE: 20210305 DATE AS OF CHANGE: 20210305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mattsson Jan CENTRAL INDEX KEY: 0001687436 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-33451 FILM NUMBER: 21716428 MAIL ADDRESS: STREET 1: C/O ALBIREO PHARMA, INC. STREET 2: 50 MILK STREET, 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALBIREO PHARMA, INC. CENTRAL INDEX KEY: 0001322505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 POST OFFICE SQUARE STREET 2: SUITE 502 SOUTH CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 857-415-4774 MAIL ADDRESS: STREET 1: 10 POST OFFICE SQUARE STREET 2: SUITE 502 SOUTH CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Biodel Inc DATE OF NAME CHANGE: 20050331 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2021-03-01 2021-03-03 0 0001322505 ALBIREO PHARMA, INC. ALBO 0001687436 Mattsson Jan C/O ALBIREO PHARMA INC. 10 POST OFFICE SQUARE, SUITE 1000 BOSTON MA 02109 0 1 0 0 Chief Scientific Officer Common Stock 2021-03-01 4 M 0 39330 1.00 A 69044 D Common Stock 2021-03-01 4 S 0 15300 37.4507 D 53744 D Common Stock 2021-03-02 4 S 0 12351 36.0749 D 41393 D Common Stock 2021-03-02 4 S 0 612 36.5447 D 40781 D Common Stock 2021-03-02 4 S 0 2807 37.1503 D 37974 D Common Stock 2021-03-03 4 S 0 400 36.2025 D 37574 D Stock Option (right to buy) 1.00 2021-03-01 4 M 0 39330 0.00 D 2021-03-18 Common Stock 39330 0 D Represents 63,544 shares of common stock and 5,500 restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.10 to $37.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above. Represents 48,244 shares of common stock and 5,500 restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above. Represents 35,893 shares of common stock and 5,500 restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.52 to $36.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above. Represents 35,281 shares of common stock and 5,500 restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above. Represents 32,474 shares of common stock and 5,500 restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above. Represents 32,074 shares of common stock and 5,500 restricted stock units. This option is fully vested. This amended Form 4 is being filed solely to correct the number of shares in Table II, Column 7 from 39,300 shares to 39,330 shares. /s/ Jason Duncan, Attorney-in-fact 2021-03-05